Prior to joining RedHill, Guy Goldberg served as Senior Vice President of Business Operations at Eagle Pharmaceuticals, a specialty injectable drug development company, based in New Jersey. Previously, Mr. Goldberg was a member of the investment team at ProQuest Investments, a healthcare focused venture capital firm. He previously served as a consultant at McKinsey & Company and holds a B.A. in Economics and Philosophy from Yale University and a J.D. from Harvard Law School.
Speaking In
[Available On-Demand]
RedHill Biopharma (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
